# US 2015/0104853 A1 · Compositions and methods of pgl for the increased production of isoprene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104853 A1
- Document ID: US20150104853A1
- Status: Published application
- Kind: A1
- Application number: 14/509,000
- Filed: 2014-10-07
- Published: 2015-04-16
- Earliest claimed: 2009-12-23
- Assignees: Danisco US Inc.; The Goodyear Tire & Rubber Company
- Applicants: Danisco US Inc.; The Goodyear Tire & Rubber Company
- Inventors: Zachary Q. BECK; Marguerite A. Cervin; Alex T. Nielsen; Caroline M. Peres
- Web page: https://patentgrep.com/patent/US20150104853A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/635: {Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 5/007: {containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}
- C12P 7/42: Hydroxy-carboxylic acids
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Provided herein are improved compositions and methods for the increased production of isoprene. Also provided herein are improved compositions and methods for the increased production of heterologous polypeptides capable of biological activity.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A composition comprising a recombinant cell of an Escherichia coli (E. coli) strain or progeny thereof, wherein the cell comprises (i) one or more copies of a heterologous nucleic acid(s) encoding a 6-phosphogluconolactonase (PGL) polypeptide wherein the nucleic acid is integrated in the E. coli chromosome and (ii) one or more heterologous nucleic acid(s) encoding isoprene synthase,
wherein prior to the integration, the E. coli does not contain nucleic acids(s) encoding a PGL polypeptide, and wherein the resulting cell produces isoprene at a greater titer than that of the same cells that do not comprise (i).

### Claim 18 (depends on 17)

The composition of claim 17, wherein the PGL polypeptide is an E. coli PGL polypeptide.

### Claim 19 (depends on 18)

The composition of claim 18, wherein nucleic acids encoding the PGL polypeptide is part of a 17,257 base pair piece as shown in FIG. 20.

### Claim 20 (depends on 17)

The composition of claim 17, wherein the cell produces isoprene at a higher specific productivity than that of the same cells that do not contain (i).

### Claim 21 (depends on 17)

The composition of claim 17, wherein the specific productivity of isoprene by the cell is at least 15 mg/OD/hr.

### Claim 22 (depends on 18)

The composition of claim 18, wherein the nucleic acid encoding PGL polypeptide is from E. coli strain K12 MG1655 or a derivative of E. coli strain K12 MG1655.

### Claim 23 (depends on 17)

The composition of claim 17, wherein the cell is of E. coli strain B.

### Claim 24 (depends on 23)

The composition of claim 23, wherein the cell is of E. coli strain BL21.

### Claim 25 (depends on 23)

The composition of claim 23, wherein the cell is of E. coli strain BL21(DE3).

### Claim 26 (depends on 17)

The composition of claim 17, wherein the cell further comprises (iii) a heterologous nucleic acid encoding an upper mevalonate (MVA) pathway polypeptide and/or a lower MVA pathway polypeptide.

### Claim 27 (depends on 26)

The composition of claim 26, wherein the upper MVA pathway polypeptide is selected from the group consisting of: (i) an acetoacetyl-Coenzyme A synthase (thiolase) polypeptide; (ii) a 3-hydroxy-3-methylglutaryl-Coenzyme A synthase polypeptide; and (iii) a 3-hydroxy-3-methylglutaryl-Coenzyme A reductase polypeptide.

### Claim 28 (depends on 26)

The composition of claim 26, wherein the lower MVA pathway polypeptide is selected from the group consisting of: (i) mevalonate kinase (MVK); (ii) phosphomevalonate kinase (PMK); (iii) diphosphomevalonate decarboxylase (MVD); and (iv) isopentenyl diphosphate isomerase (IDI).

### Claim 29 (depends on 17)

The composition of claim 17, wherein the isoprene synthase polypeptide is from Pueraria or Populus or Populus alba×Populus tremula or a variant thereof.

### Claim 30 (depends on 29)

The composition of claim 29, wherein the isoprene synthase polypeptide is from Populus alba or a variant thereof.
